Literature DB >> 25846555

Alternative sunitinib schedules in metastatic renal cell carcinoma and the RAINBOW study.

S Bracarda1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25846555     DOI： 10.1093/annonc/mdv168

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  1 in total

1.  Phase II Study of Two Weeks on, One Week off Sunitinib Scheduling in Patients With Metastatic Renal Cell Carcinoma.

Authors:  Eric Jonasch; Rebecca S Slack; Daniel M Geynisman; Elshad Hasanov; Matthew I Milowsky; W Kimryn Rathmell; Summer Stovall; Donna Juarez; Troy R Gilchrist; Lisa Pruitt; Moshe C Ornstein; Elizabeth R Plimack; Nizar M Tannir; Brian I Rini
Journal:  J Clin Oncol       Date:  2018-04-11       Impact factor: 44.544
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.